Shandong Sito Bio-technology Co Ltd (300583) — Working Capital to Net Assets Ratio
Shandong Sito Bio-technology Co Ltd (300583) has a Working Capital to Net Assets ratio of 14.8% as of March 2026. Working capital of CN¥266.29 Million (current assets of CN¥1.25 Billion minus current liabilities of CN¥984.78 Million) is measured against net assets of CN¥1.80 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shandong Sito Bio-technology Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shandong Sito Bio-technology Co Ltd Working Capital to Net Assets (2012–2025)
This chart shows how Shandong Sito Bio-technology Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 14.8%, reflecting working capital of CN¥266.29 Million against net assets of CN¥1.80 Billion CNY. For the complete balance sheet picture, see 300583 total assets.
Annual Working Capital to Net Assets for Shandong Sito Bio-technology Co Ltd (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shandong Sito Bio-technology Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 300583 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 15.5% | CN¥278.66 Million | CN¥1.80 Billion | CN¥1.28 Billion | CN¥1.01 Billion | ▲ +1.6 pp |
| 2024 | 13.9% | CN¥261.24 Million | CN¥1.88 Billion | CN¥1.28 Billion | CN¥1.02 Billion | ▼ -6.0 pp |
| 2023 | 19.9% | CN¥411.03 Million | CN¥2.07 Billion | CN¥1.40 Billion | CN¥986.76 Million | ▲ +16.8 pp |
| 2022 | 3.1% | CN¥55.48 Million | CN¥1.77 Billion | CN¥1.14 Billion | CN¥1.08 Billion | ▲ +1.7 pp |
| 2021 | 1.5% | CN¥25.31 Million | CN¥1.73 Billion | CN¥1.08 Billion | CN¥1.05 Billion | ▼ -10.4 pp |
| 2020 | 11.9% | CN¥201.38 Million | CN¥1.69 Billion | CN¥1.14 Billion | CN¥940.73 Million | ▼ -18.0 pp |
| 2019 | 29.9% | CN¥563.65 Million | CN¥1.89 Billion | CN¥1.51 Billion | CN¥943.05 Million | ▼ -22.0 pp |
| 2018 | 51.9% | CN¥966.24 Million | CN¥1.86 Billion | CN¥1.67 Billion | CN¥704.13 Million | ▼ -8.4 pp |
| 2017 | 60.3% | CN¥1.03 Billion | CN¥1.71 Billion | CN¥1.34 Billion | CN¥306.56 Million | ▲ +26.4 pp |
| 2016 | 33.9% | CN¥204.22 Million | CN¥603.01 Million | CN¥367.88 Million | CN¥163.66 Million | ▼ -3.7 pp |
| 2015 | 37.5% | CN¥190.10 Million | CN¥506.66 Million | CN¥370.07 Million | CN¥179.97 Million | ▲ +21.1 pp |
| 2014 | 16.5% | CN¥47.87 Million | CN¥290.80 Million | CN¥152.63 Million | CN¥104.75 Million | ▼ -53.2 pp |
| 2013 | 69.7% | CN¥68.87 Million | CN¥98.83 Million | CN¥135.51 Million | CN¥66.63 Million | ▲ +57.0 pp |
| 2012 | 12.7% | CN¥4.12 Million | CN¥32.47 Million | CN¥31.63 Million | CN¥27.51 Million | — |